
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
CME Quiz
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Coronary Heart Disease in the United Statesalmost 28 years ago
Mechanisms of Acute Coronary Eventsalmost 28 years ago
Primary Preventionalmost 28 years ago
Pravastatin Event Reduction Analysisalmost 28 years ago
Secondary Preventionalmost 28 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?almost 28 years ago
Methods and Mindsets in Pharmacoeconomicsalmost 28 years ago
Issues and Controversies in PharmacoeconomicsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
3
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
4
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
5









